Intravitreal Ziv-Aflibercept in Patients With Diabetic Macular Edema Refractory to Intravitreal Bevacizumab-Reference-Cited by-同舟云学术

Intravitreal Ziv-Aflibercept in Patients With Diabetic Macular Edema Refractory to Intravitreal Bevacizumab

Published:2020-03 Issue:3 Volume:51 Page:145-151
ISSN:2325-8160
Container-title:Ophthalmic Surgery, Lasers and Imaging Retina
language:en
Short-container-title:Ophthalmic Surg Lasers Imaging Retina

Author:

Ebrahimiadib Nazanin,Lashay Alireza,Riazi-Esfahani Hamid,Jamali Sepideh,Khodabandeh Alireza,Zarei Mohammad,Roohipoor Ramak,Khojasteh Hassan,Bazvand Fatemeh,Ojani Mina,Shahabinejad Mojtaba,Yaseri Mehdi,Modjtahedi Bobeck S.,Davoudi Samaneh,Riazi-Esfahani Mohammad

Publisher

SLACK, Inc.

Subject

Ophthalmology,Surgery

Reference23 articles.

1. Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy

2. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

3. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment

4. Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration

5. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of intravitreal injection of Ziv-aflibercept before vitrectomy for proliferative diabetic retinopathy;Delta Journal of Ophthalmology;2024-04

2. Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods;Survey of Ophthalmology;2023-03

3. Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema;International Journal of Retina and Vitreous;2022-10-12

4. Monoclonal antibodies in diabetic retinopathy;Expert Review of Clinical Immunology;2022-02-01

5. Ziv-aflibercept for Better Regulating Neovascular Age-Related Macular Degeneration (ZEBRA): A Prospective, Randomized Trial;Seminars in Ophthalmology;2021-02-12